Biotech Values

[walldiver]

Re DNDN and 9902A

<<When I think about it, yes its possible, even probable, that the hedgies knew that 9902a would not hit the survival endpoint. Probably not Dr. Higano, but they had other ways to find out.>>

Probably from the company itself, as every time someone at DNDN spoke publicly about 9902A survival between February and July, they said it was unlikely to be stat sig. Also, IR and the CFO always said this when telephoned, so I imagine that Dr. Gold always said the same thing over the phone.

It's much more likely, if Dr. Higano divulged any confidential info about the DNDN Phase 3 trials, that it was about the enrollment status of 9902B.